- Home
- LENZ vs MDXG Comparison
LENZ vs MDXG Comparison
Compare LENZ & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- MDXG
- Stock Information
- Founded
- LENZ 2019
- MDXG 2006
- Country
- LENZ United States
- MDXG United States
- Employees
- LENZ N/A
- MDXG N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- LENZ Health Care
- MDXG Health Care
- Exchange
- LENZ Nasdaq
- MDXG Nasdaq
- Market Cap
- LENZ 1.2B
- MDXG 1.0B
- IPO Year
- LENZ 2021
- MDXG N/A
- Fundamental
- Price
- LENZ $39.70
- MDXG $6.59
- Analyst Decision
- LENZ Strong Buy
- MDXG Buy
- Analyst Count
- LENZ 4
- MDXG 1
- Target Price
- LENZ $49.75
- MDXG $12.00
- AVG Volume (30 Days)
- LENZ 546.3K
- MDXG 704.2K
- Earning Date
- LENZ 11-05-2025
- MDXG 10-29-2025
- Dividend Yield
- LENZ N/A
- MDXG N/A
- EPS Growth
- LENZ N/A
- MDXG N/A
- EPS
- LENZ N/A
- MDXG 0.21
- Revenue
- LENZ $5,000,000.00
- MDXG $363,774,000.00
- Revenue This Year
- LENZ N/A
- MDXG $12.68
- Revenue Next Year
- LENZ $285.82
- MDXG $8.18
- P/E Ratio
- LENZ N/A
- MDXG $33.82
- Revenue Growth
- LENZ N/A
- MDXG 6.85
- 52 Week Low
- LENZ $16.54
- MDXG $5.47
- 52 Week High
- LENZ $50.40
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- LENZ 42.78
- MDXG 38.00
- Support Level
- LENZ $45.20
- MDXG $6.62
- Resistance Level
- LENZ $49.25
- MDXG $7.35
- Average True Range (ATR)
- LENZ 2.80
- MDXG 0.24
- MACD
- LENZ -0.46
- MDXG -0.03
- Stochastic Oscillator
- LENZ 4.00
- MDXG 8.28
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.